Literature DB >> 15896758

Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: an observational study.

Serban C Stoica1, Carl Atkinson, Duwarakan K Satchithananda, Susan Charman, Martin Goddard, Andrew N Redington, Stephen R Large.   

Abstract

BACKGROUND: Endothelial activation in the donor heart has been described variably after brain death and transplantation. We aimed to characterize the time course of endothelial activation in right ventricle (RV) and left ventricle (LV) during the acute phase of clinical transplantation.
METHODS: We studied biopsy specimens from the RVs and the LVs of 40 donor hearts: at initial assessment of the donor, at end-ischemia, and after 10 minutes of reperfusion. We also included follow-up RV biopsy specimens at 1 week, 1 month, and 3 months after surgery. Six of the patients had cystic fibrosis and were domino donors.
RESULTS: P-selectin and vascular cell adhesion molecule 1 (VCAM-1), but not E-selectin were up-regulated in brain-dead and in domino donors vs controls. Unused donor hearts (n = 6) had significantly less up-regulation of P-selectin and of VCAM-1. We found no difference between the RV and the LV during surgery, but we did see important time-dependent variations. P-selectin was present in 85% of vessels throughout transplantation and decreased to approximately 60% after transplantation (p < 0.001). We initially detected VCAM-1 in 20% of vessels, which decreased to 5% during storage, then increased to 47% at reperfusion, and gradually decreased thereafter (p < 0.001). E-selectin expression increased progressively from 15% initially to 45% at reperfusion and then decreased after surgery (p = 0.001). Thrombomodulin expression was decreased at baseline, and the decrease was accentuated afterward (p = 0.02). Patients with donor organ failure did not have a specific pattern of endothelial activation.
CONCLUSION: Cardiac transplantation is associated with marked endothelial activation, with no difference between the two ventricles. The changes persist in the post-operative period, even in the absence of acute rejection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896758     DOI: 10.1016/j.healun.2004.01.021

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging.

Authors:  Asim M Akhtar; Jurgen E Schneider; Stephanie J Chapman; Andrew Jefferson; Janet E Digby; Kulveer Mankia; Ye Chen; Martina A McAteer; Kathryn J Wood; Robin P Choudhury
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

2.  Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.

Authors:  Carl Atkinson; Bernhard Floerchinger; Fei Qiao; Sarah Casey; Tucker Williamson; Ellen Moseley; Serban Stoica; Martin Goddard; Xupeng Ge; Stefan G Tullius; Stephen Tomlinson
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

3.  Complement-dependent inflammation and injury in a murine model of brain dead donor hearts.

Authors:  Carl Atkinson; Juan C Varela; Stephen Tomlinson
Journal:  Circ Res       Date:  2009-10-08       Impact factor: 17.367

Review 4.  Inflammation in Right Ventricular Failure: Does It Matter?

Authors:  Laurence Dewachter; Céline Dewachter
Journal:  Front Physiol       Date:  2018-08-20       Impact factor: 4.566

5.  Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.

Authors:  Martina Bona; Rahel K Wyss; Maria Arnold; Natalia Méndez-Carmona; Maria N Sanz; Dominik Günsch; Lucio Barile; Thierry P Carrel; Sarah L Longnus
Journal:  J Am Heart Assoc       Date:  2021-01-30       Impact factor: 5.501

Review 6.  An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.

Authors:  Martina A McAteer; Asim M Akhtar; Constantin von Zur Muhlen; Robin P Choudhury
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.